Type and maturational status of dendritic cells in cutaneous B cell lymphoproliferative disorders

Histopathology

Volumn 59, Issue 3, 2011, Pages 421-432

  Christie, Lesley J ^a   MacKenzie, Carol ^b   Palmer, Timothy J ^b   Baker, Lee ^a   Goodlad, John R ^a,c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b RAIGMORE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

B cutaneous lymphoid hyperplasia; Cutaneous mucosa associated lymphoid tissue lymphoma; Dendritic cells; Plasmacytoid dendritic cell

Indexed keywords

BDCA 2 PROTEIN; BLOOD CLOTTING FACTOR 8A; CD123 ANTIGEN; CD20 ANTIGEN; CD209 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD83 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLIN D1; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; LANGERIN; PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; B CELL CUTANEOUS LYMPHOID HYPERPLASIA; CELL ACTIVATION; CELL ACTIVITY; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LYMPH FOLLICLE; LYMPHOCYTE PROLIFERATION; LYMPHOID HYPERPLASIA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PLASMA CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

B-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISORDERS; SKIN NEOPLASMS;

EID: 80053337317     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03967.x     Document Type: Article

References (61)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392; 245-252.
2. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449; 419-426.
3. Pulendran B, Tang H, Denning TL. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 2008; 20; 61-67.
4. Ebner S, Ehammer Z, Holzmann S et al. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int. Immunol. 2004; 16; 877-887.
5. Lechmann M, Krooshoop DJ, Dudziak D et al. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 2001; 194; 1813-1821.
6. de Saint-Vis B, Vincent J, Vandenabeele S et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998; 9; 325-336.
7. Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T. Dendritic cells: biology of the skin. Contact Derm. 2009; 60; 2-20.
8. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells [Review]. Science 2000; 290; 92-97.
9. De Jong EC, Smits HH, Kaspenberg ML. Dendritic cell-mediated T cell polarization [Review]. Springer Semin. Immunopathol. 2005; 26; 289-307.
10. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003; 21; 685-711.
11. Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. J. Dermatol. Sci. 2007; 45; 77-86.
12. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhan cells. Nat. Rev. Immunol. 2002; 2; 77-84.
13. Aarnoudse CA, Garcia Vallejo JJ, Saeland E, van Kooyk Y. Recognition of tumor glycans by antigen-presenting cells. Curr. Opin. Immunol. 2006; 18; 105-111.
14. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Langerin, a novel C-type lectin specific to Langerhan's cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12; 71-81.
15. Geijtenbeek TBH, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100; 575-585.
16. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol. 2004; 25; 242-248.
17. Cao X, Sugita M, Van Der Wel N et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J. Immunol. 2002; 169; 4770-4777.
18. Töröcsik D, Bárdos H, Nagy L, Adány R. Identification of factor XIII-A as a marker of alternative macrophage activation. Cell. Mol. Life Sci. 2005; 62; 2132-2139.
19. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 1993; 151; 6535-6545.
20. Colonna M, Trichieri G, Liu Y-J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004; 5; 1219-1226.
21. Nihal M, Mikkola D, Horvath N et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum. Pathol. 2003; 34; 617-622.
22. Carbonnelle A, Martin-Garcia N, Ortonne N et al. Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin. Virchows Arch. 2007; 450; 441-447.
23. Pigozzi B, Bordignon M, Belloni Fortina A, Michelotto G, Alaibac M. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol. Rep. 2006; 15; 347-351.
24. Schmuth M, Sidoroff A, Danner B, Topar G, Sepp NT. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma. Am. J. Clin. Pathol. 2001; 116; 72-78.
25. Kutzner H, Kerl H, Pfaltz MC, Kempf W. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am. J. Surg. Pathol. 2009; 33; 1307-1313.
26. Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am. J. Surg. Pathol. 1999; 23; 88-96.
27. Burg G, Kempf W, Cozzio A et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J. Cutan. Pathol. 2005; 32; 647-674.
28. Zaba LC, Krueger JG, Lowes MA. Resident and 'inflammatory' dendritic cells in human skin. J. Invest. Dermatol. 2009; 129; 302-308.
29. Zaba LC, Fuente-Duculan J, Steinman RM et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+ FXIIIA+ macrophages. J. Clin. Invest. 2007; 117; 2517-2525.
30. Nestle FO, Nickoloff BJ. Deepening our understanding of immune sentinels in the skin. J. Clin. Invest. 2007; 117; 2382-2385.
31. Narbutt J, Lesiak A, Sysa-Jedrzejowska A, Smolewski P, Robak T, Zalewska A. The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects. Folia Histochem. Cytobiol. 2006; 44; 61-63.
32. Wollenberg A, Wagner M, Günther S et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 2002; 119; 1096-1102.
33. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J. Allergy Clin. Immunol. 2007; 119; 1210-1217.
34. Lowes MA, Chamian F, Abello MV et al. Increase in TNF-alpha and inducible nitric oxide synthetase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl Acad. Sci. USA 2005; 102; 19057-19062.
35. Eckert F, Schmid U. Identification of plasmacytoid T cells in lymphoid hyperplasia of the skin. Arch. Dermatol. 1989; 11; 1518-1524.
36. Gottenberg JE, Cagnard N, Lucchesi C et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc. Natl Acad. Sci. USA 2006; 103; 2770-2775.
37. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's syndrome. Arthritis Rheum. 1999; 42; 1765-1772.
38. Valladeau J, Saeland S. Cutaneous dendritic cells. Semin. Immunol. 2005; 17; 273-283.
39. Soilleux EJ, Morris LS, Leslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 2002; 71; 445-457.
40. Mahnke K, Knop J, Enk AH. Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol. 2003; 24; 646-651.
41. Santegoets SJ, Gibbs S, Kroeze K et al. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J. Leukoc. Biol. 2008; 84; 143-151.
42. Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001; 194; 1823-1834.
43. McKenna K, Beignon A-S, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 2005; 79; 17-27.
44. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J. Leukoc. Biol. 2004; 75; 504-514.
45. Poeck H, Wagner M, Battiany J et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004; 103; 3058-3064.
46. Santini SM, Lapenta C, Logozzi M et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000; 191; 1777-1788.
47. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligonucleotides induce the generation of CD4+ CD25+ regulatory T cells. J. Immunol. 2004; 173; 4433-4442.
48. O'Keeffe M, Hochrein H, Vremec D et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 2002; 196; 1307-1319.
49. Kohrgruber N, Groger M, Meraner P et al. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J. Immunol. 2004; 173; 6592-6602.
50. Vermi W, Riboldi E, Wittamer V et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 2005; 201; 509-515.
51. Kempf W, Kerl H, Kutzner H. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: a crucial role and a new lymphoma paradigm. Am. J. Dermatopathol. 2010; 32; 194-196.
52. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum. Immunol. 2002; 63; 1156-1163.
53. Liu Y. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005; 23; 275-306.
54. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001; 22; 394-400.
55. Dubois B, Barthélémy C, Durand I, Liu YJ, Caux C, Brière F. Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching. J. Immunol. 1999; 162; 3428-3436.
56. Litinsky MB, Nardelli B, Hilbert DM et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002; 3; 822-829.
57. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19; 225-234.
58. Kempf W, Ralfkiaer E, Duncan L et al. Cutaneous marginal zone B-cell lymphoma. In LeBoit PE, Burg G, Weedon D, Sarasin A eds. World Health Organization classification of tumours. Skin tumours. Lyon: IARC Press, 2006; 198-199.
59. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90; 354-371.
60. LeBoit PE, McNutt NS, Reed JA, Jacobson M, Weiss LM. Primary cutaneous immunocytoma. Am. J. Surg. Pathol. 1994; 18; 969-978.
61. Rijlaarsdam JU, van der Putte SCJ, Berti E et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993; 23; 117-125.